A low incidence of new-onset insulin-dependent diabetes mellitus using tacrolimus in kidney recipients in Europe.
暂无分享,去创建一个
J. Pascual | R. Marcén | J. Ortuño | F. Liaño | F. Burgos | A. Tato | M. Tenorio
[1] R. Margreiter. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study , 2002, The Lancet.
[2] J. Pascual,et al. Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy. , 2002, Transplantation proceedings.
[3] M. Nicholson,et al. European randomised trial of dual versus triple tacrolimus-based regimens for control of acute rejection in renal allograft recipients , 2001, Transplant international : official journal of the European Society for Organ Transplantation.
[4] J. Squifflet,et al. INDUCTION VERSUS NONINDUCTION IN RENAL TRANSPLANT RECIPIENTS WITH TACROLIMUS-BASED IMMUNOSUPPRESSION1 , 2001, Transplantation.
[5] J. Squifflet,et al. DOSE OPTIMIZATION OF MYCOPHENOLATE MOFETIL WHEN ADMINISTERED WITH A LOW DOSE OF TACROLIMUS IN CADAVERIC RENAL TRANSPLANT RECIPIENTS , 2001, Transplantation.
[6] D Talbot,et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. , 1997, Transplantation.
[7] Joshua Miller,et al. A Comparison Of Tacrolimus (fk506) And Cyclosporine For Immunosuppression After Cadaveric Renal Transplantation1 , 1997 .